Delivery Order SPE2DB20D2104-SPE2DB25FNASF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,328.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 11, 2025, with a completion date of September 12, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication indicated for migraine treatment, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $3,427.02 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication used to manage acute migraine episodes,...
- The Defense Logistics Agency awarded a delivery order valued at $6,972.88 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the breadth of...
- The Defense Logistics Agency awarded a $11,630.45 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on September 4, 2025, with a completion date of September 5, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the Defense Logistics Agency's ongoing procurement of...
- The Defense Logistics Agency awarded a delivery order valued at $9,418.24 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This competitively awarded, non-set-aside delivery order is scheduled for completion by August 8, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the Defense Logistics Agency's ongoing procurement of pharmaceutical...
- The Defense Logistics Agency awarded a $47,367.48 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a prescription medication used for the acute treatment of migraine, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $14,227.22 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $5,803.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (eight-count supply) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for migraine treatment, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,973.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the...
- The Defense Logistics Agency awarded a delivery order valued at $54,649.34 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for the acute treatment of migraine,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FNASFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,701.78 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract awarded on September 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription migraine treatment medication, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military and federal healthcare systems. This delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a maximum value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies an extensive range of medications, vaccines, and medical supplies to support military healthcare programs globally. The company's competitive award history and established position as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare entities demonstrate its capability to meet specialized medical procurement needs efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 9/17/25 |